Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milo Gatti

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Acta Diabetologica|November 12, 2018
Feasibility of FreeStyle Libre Flash Glucose Monitoring System in pregnant woman affected by type 1 diabetesMilo Gatti
Journal of Chemotherapy (Florence, Italy)|March 4, 2020
Pharmacokinetic analysis investigating gentamicin dosing in a major burned patient complicated by septic shockMilo Gatti
Clinical Pharmacokinetics|September 4, 2022
The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug-Disease Interaction Under Different Clinical ConditionsMilo Gatti, Federico Pea
Expert Review of Anti-Infective Therapy|January 19, 2023
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactamsMilo Gatti, Federico Pea
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2024
Is a High Baseline Inflammatory Burden the Major Driver in Causing Daptomycin-induced Eosinophilic Pneumonia and Muscular Toxicity?Milo Gatti, Federico Pea
Expert Opinion on Pharmacotherapy|March 24, 2026
Pharmacological approaches to overcome antimicrobial resistance to novel beta-lactams in MDR Gram-negative bacterial infections: Current practice and future directionsMilo Gatti, Federico Pea
Expert Review of Anti-Infective Therapy|December 24, 2025
Pharmacokinetics-pharmacodynamics perspective to optimizing therapy with beta-lactams in critically ill patients: an updateMilo Gatti, Federico Pea
Frontiers in Antibiotics|January 16, 2025
Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive reviewMilo Gatti, Federico Pea
Current Opinion in Infectious Diseases|July 15, 2021
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infectionsMilo Gatti, Federico Pea
Clinical Pharmacokinetics|June 14, 2021
Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel AntibioticsMilo Gatti, Federico Pea
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Acta Diabetologica|November 12, 2018
Feasibility of FreeStyle Libre Flash Glucose Monitoring System in pregnant woman affected by type 1 diabetesMilo Gatti
Journal of Chemotherapy (Florence, Italy)|March 4, 2020
Pharmacokinetic analysis investigating gentamicin dosing in a major burned patient complicated by septic shockMilo Gatti
Clinical Pharmacokinetics|September 4, 2022
The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug-Disease Interaction Under Different Clinical ConditionsMilo Gatti, Federico Pea
Expert Review of Anti-Infective Therapy|January 19, 2023
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactamsMilo Gatti, Federico Pea
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2024
Is a High Baseline Inflammatory Burden the Major Driver in Causing Daptomycin-induced Eosinophilic Pneumonia and Muscular Toxicity?Milo Gatti, Federico Pea
Expert Opinion on Pharmacotherapy|March 24, 2026
Pharmacological approaches to overcome antimicrobial resistance to novel beta-lactams in MDR Gram-negative bacterial infections: Current practice and future directionsMilo Gatti, Federico Pea
Expert Review of Anti-Infective Therapy|December 24, 2025
Pharmacokinetics-pharmacodynamics perspective to optimizing therapy with beta-lactams in critically ill patients: an updateMilo Gatti, Federico Pea
Frontiers in Antibiotics|January 16, 2025
Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive reviewMilo Gatti, Federico Pea
Current Opinion in Infectious Diseases|July 15, 2021
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infectionsMilo Gatti, Federico Pea
Clinical Pharmacokinetics|June 14, 2021
Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel AntibioticsMilo Gatti, Federico Pea
Pageof 17